Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Abdulmajeed Aydh, Reza Sari Motlagh, Mohammad Abufaraj, Keiichiro Mori, Satoshi Katayama, Nico Grossmann, Pawel Rajwa, Hadi Mostafai, Ekaterina Laukhtina, Benjamin Pradere, Fahad Quhal, Victor M. Schuettfort, Alberto Briganti, Pierre I. Karakiewicz, Haron Fajkovic & Shahrokh F. Shariat. (2022) Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: An updated systematic review and meta-analysis. Arab Journal of Urology 20:2, pages 71-80.
Read now
Read now
Deepak Kumar, Kavindra Nath, Hira Lal & Ashish Gupta. (2021) Noninvasive urine metabolomics of prostate cancer and its therapeutic approaches: a current scenario and future perspective. Expert Review of Proteomics 18:11, pages 995-1008.
Read now
Read now
Lisa Moris, Gaëtan Devos, Thomas Van den Broeck, Daimantas Milonas, Maarten Albersen, Charlien Berghen, Gert De Meerleer, Wout Devlies, Wouter Everaerts, Thomas Gevaert, Hendrik Van Poppel, Frank Claessens & Steven Joniau. (2021) Current and emerging therapies for localized high-risk prostate cancer. Expert Review of Anticancer Therapy 21:3, pages 267-282.
Read now
Read now
Hui Wang, Lidong Chen, Jun Zhou, Sheng Tai & Chaozhao Liang. (2020) Development of Mobile Application for Dynamically Monitoring the Risk of Prostate Cancer and Clinicopathology. Cancer Management and Research 12, pages 12175-12184.
Read now
Read now
Articles from other publishers (15)
Terence Tang, George Rodrigues, Andrew Warner & Glenn Bauman. (2024) Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update From the FASTR/FASTR-2 Trials. Practical Radiation Oncology 14:1, pages e48-e56.
Crossref
Crossref
Hung-Jen Shih, Shyh-Chyi Chang, Chia-Hao Hsu, Yi-Chu Lin, Chu-Hsuan Hung & Szu-Yuan Wu. (2021) Comparison of Clinical Outcomes of Radical Prostatectomy versus IMRT with Long-Term Hormone Therapy for Relatively Young Patients with High- to Very High-Risk Localized Prostate Cancer. Cancers 13:23, pages 5986.
Crossref
Crossref
David E Guy, Hanbo Chen, R Gabriel Boldt, Joseph Chin & George Rodrigues. (2021) Characterizing Surgical and Radiotherapy Outcomes in Non-metastatic High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis. Cureus.
Crossref
Crossref
Fei Wang, Yuanming Fan, Xiaojian Yin, Lian-Wen Qi, Gaoxiang Ma & Qinbo Yuan. (2021) Prognostic comparison between radical prostatectomy and radiotherapy in prostate cancer patients at different stages and ages. Aging 13:12, pages 16773-16785.
Crossref
Crossref
Kirsti Aas, Viktor Berge, Tor Åge Myklebust & Sophie Dorothea Fosså. (2021) Comparative Survival Outcomes of High-risk Prostate Cancer Treated with Radical Prostatectomy or Definitive Radiotherapy Regimens. European Urology Open Science 26, pages 55-63.
Crossref
Crossref
Sophie D. Fosså, Kirsti Aas, Christoph. Müller, Marianne B. Jerm, Torgrim Tandstad, Wolfgang Lilleby, Rune Kvåle, Johanne Gulbrandsen, Erik Haug & Tor A. Myklebust. (2021) Definitive radiotherapy for prostate cancer in Norway 2006–2015: Temporal trends, performance and survival. Radiotherapy and Oncology 155, pages 33-41.
Crossref
Crossref
Zhipeng Wang, Yuchao Ni, Junru Chen, Guangxi Sun, Xingming Zhang, Jinge Zhao, Xudong Zhu, Haoran Zhang, Sha Zhu, Jindong Dai, Pengfei Shen & Hao Zeng. (2020) The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis. World Journal of Surgical Oncology 18:1.
Crossref
Crossref
Satoru Taguchi, Kenshiro Shiraishi & Hiroshi Fukuhara. (2020) Updated evidence on oncological outcomes of surgery versus external beam radiotherapy for localized prostate cancer. Japanese Journal of Clinical Oncology 50:9, pages 963-969.
Crossref
Crossref
Bo Liu, Hong Wei, Yan-Jun Ren, Debo Zou, Kaining Zhang, Qingwei Ma & Xing Xiao. (2020) Clinicopathological characteristics and survival of malignant fibrous histiocytoma of the bone: A population-based study using the SEER database. PLOS ONE 15:6, pages e0232466.
Crossref
Crossref
Lisa Moris, Marcus G. Cumberbatch, Thomas Van den Broeck, Giorgio Gandaglia, Nicola Fossati, Brian Kelly, Raj Pal, Erik Briers, Philip Cornford, Maria De Santis, Stefano Fanti, Silke Gillessen, Jeremy P. Grummet, Ann M. Henry, Thomas B.L. Lam, Michael Lardas, Matthew Liew, Malcolm D. Mason, Muhammad Imran Omar, Olivier Rouvière, Ivo G. Schoots, Derya Tilki, Roderick C.N. van den Bergh, Theodorus H. van Der Kwast, Henk G. van Der Poel, Peter-Paul M. Willemse, Cathy Y. Yuan, Badrinath Konety, Tanya Dorff, Suneil Jain, Nicolas Mottet & Thomas Wiegel. (2020) Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review. European Urology 77:5, pages 614-627.
Crossref
Crossref
Benjamin A. Greenberger, Nicholas G. Zaorsky & Robert B. Den. (2020) Comparison of Radical Prostatectomy Versus Radiation and Androgen Deprivation Therapy Strategies as Primary Treatment for High-risk Localized Prostate Cancer: A Systematic Review and Meta-analysis. European Urology Focus 6:2, pages 404-418.
Crossref
Crossref
Smriti Singh, James Ted McDonald, Gabriela Ilie & Anil Adisesh. (2020) An examination of the association between lifetime history of prostate and pancreatic cancer diagnosis and occupation in a population sample of Canadians. PLOS ONE 15:2, pages e0227622.
Crossref
Crossref
Benjamin A. Greenberger, James M. Taylor, Victor E. Chen & Robert B. Den. (2020) Comparing Radiotherapy to Prostatectomy for High-Risk Prostate Cancer. The Cancer Journal 26:1, pages 29-37.
Crossref
Crossref
Benjamin A. Greenberger, Victor E. Chen & Robert B. Den. (2019) Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions. Frontiers in Oncology 9.
Crossref
Crossref
Wei-dong Jiang & Ping-cheng Yuan. (2019) Development and validation of prognostic nomograms for patients with metastatic prostate cancer. International Urology and Nephrology 51:10, pages 1743-1753.
Crossref
Crossref